MABVAX Trademark Information

MabVax Therapeutics, Inc.

Radiopharmaceutical imaging and detection agents developed using monoclonal antibodies for diagnosing and monitoring cancer; Diagnostic kits consisting primarily of monoclonal antibodies, and reagents for use in disease testing; Therapeutic pharmaceuticals developed using monoclonal antibodies for the treatment of cancer and other malignancies

Perfect for these industries

This is a brand page for the MABVAX trademark by MabVax Therapeutics, Inc.  in San Diego, CA, 92121.

Write a review about a product or service associated with this MABVAX trademark. Or, contact the owner MabVax Therapeutics, Inc. of the MABVAX trademark by filing a request to communicate with the Legal Correspondent for licensing, use, and/or questions related to the MABVAX trademark.

On Thursday, May 19, 2016, a U.S. federal trademark registration was filed for MABVAX. The USPTO has given the MABVAX trademark serial number of 87043574. The current federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE. The correspondent listed for MABVAX is BRENT D. SOKOL, ANNA E. RAIMER of JONES DAY, 555 SOUTH FLOWER STREET, 50TH FLOOR, LOS ANGELES, CA 90071 . The MABVAX trademark is filed in the category of Pharmaceutical Products . The description provided to the USPTO for MABVAX is Radiopharmaceutical imaging and detection agents developed using monoclonal antibodies for diagnosing and monitoring cancer; Diagnostic kits consisting primarily of monoclonal antibodies, and reagents for use in disease testing; Therapeutic pharmaceuticals developed using monoclonal antibodies for the treatment of cancer and other malignancies.

Word mark: MABVAX
Status/Status Date:
ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
12/17/2018
Serial Number: 87043574
Filing Date: 5/19/2016
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Radiopharmaceutical imaging and detection agents developed using monoclonal antibodies for diagnosing and monitoring cancer; Diagnostic kits consisting primarily of monoclonal antibodies, and reagents for use in disease testing; Therapeutic pharmaceuticals developed using monoclonal antibodies for the treatment of cancer and other malignancies
Mark Description: NOT AVAILABLE
Type Of Mark: TradeMark
Published For Opposition Date: N/A
Last Applicant/Owner: MabVax Therapeutics, Inc.
San Diego, CA 92121
Mark Drawing Code: Standard Character Mark
Design Search: (NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
JONES DAY
555 SOUTH FLOWER STREET, 50TH FLOOR
LOS ANGELES, CA 90071

Classification Information

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere: : Not provided
First Use In Commerce: Not provided

Trademarkia is the largest search engine for U.S. trademarks. Each month hundreds of trademarks around the world are filed by licensed attorneys in the Trademarkia Network Law firms! You can register your trademark in 170+ countries in the world through Trademarkia Network Law firms.

Trademarkia-Network law firms can help you incorporate a business around your MABVAX trademark in less than 5 minutes. Trademarkia makes the process easy and convenient, so start now!

Trademarkia.com is a free search engine of publicly available government records. Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.

Trademark Document Retrieval >>

100% Satisfaction Guarantee protect your valuable brand now.

  • 1. Trademarkia Network law firm - #1 U.S. Trademark Filing from 2010 to now.
  • 2. Describe how your business or product is being used. Register your mark in 176+ countries. Starting $399/class + govt fees! Click here >>
  • 1. Top Global Specialist - Credibility and Experience!
  • 2. All processes will be performed in a timely manner.
Current Trademark Status:
12/17/2018
ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Correspondent Search:

BRENT D. SOKOL, ANNA E. RAIMER is a correspondent of MABVAX trademark.

Current Overall Rating:
RatingRatingRatingRatingRating (0 review)
What You Can Do: